NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
Henan Cancer Hospital
Fujian Cancer Hospital
Tang-Du Hospital
Shanghai Zhongshan Hospital
Fondazione Ricerca Traslazionale